{"transactions":[{"id":866722,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:29.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007646/form4.xml","form_type":"4"}},{"id":1081376,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:51.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027402","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027402/form4.xml","form_type":"4"}},{"id":1723748,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-04T23:14:58.000Z","date":"2023-12-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":5.28,"expiration_date":"2033-12-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-23-056240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123056240/form4.xml","form_type":"4"}},{"id":4370219,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2017-03-28T16:35:17.000Z","date":"2017-03-24","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such stock options vest 25% on March 24, 2018 and in twelve equal increments on a quarterly basis beginning three months after that. The stock options have a term of ten years."}],"balance_after":54000,"derivative":{"exercise_price":3.45,"expiration_date":"2027-03-23","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001472343-17-000022","document":"wf-form4_149073329751227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403893/000147234317000022/wf-form4_149073329751227.xml","form_type":"4"}},{"id":4560572,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2016-11-10T16:16:33.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":25,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the \"Series A Preferred Shares\")  automatically converted into shares of the Company's common stock, par value $0.001 (the \"Common Shares\") at a conversion price of $7.00 per share resulting in his acquisition of 3,572 Common Shares.  Common Shares disclosed reflect the October 11, 2016, 10 for 1 reverse stock split of the Company's Common Shares.  The Series A Preferred Shares were adjusted proportionately and consequently, each share of Preferred Stock became convertible into approximately 143 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common stock, par value $0.001 per share","underlying_shares":3572},"source":{"system":"sec-edgar","filing":"0001472343-16-000238","document":"wf-form4_147881257960648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403893/000147234316000238/wf-form4_147881257960648.xml","form_type":"4"}},{"id":4560571,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common Stock, $0.001 par value per share","published_at":"2016-11-10T16:16:33.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":3572,"price":7,"value":25004.0,"ownership":{"direct":true},"balance_after":8938,"source":{"system":"sec-edgar","filing":"0001472343-16-000238","document":"wf-form4_147881257960648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403893/000147234316000238/wf-form4_147881257960648.xml","form_type":"4"}},{"id":4596069,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Warrant (right to buy)","published_at":"2016-09-23T16:31:19.000Z","date":"2016-09-21","kind":"purchase","acquired":true,"shares":35714,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person purchased 25 Series A Preferred Shares and five-year warrants to purchase 35,714 Common Shares at a purchase price of $1,000 per share pursuant to a private offering of the Company for a total of $25,000."}],"balance_after":35714,"derivative":{"exercise_price":0.7,"exercise_date":"2016-09-21","expiration_date":"2016-09-21","underlying":"Common stock, par value $0.001 per share","underlying_shares":35714},"source":{"system":"sec-edgar","filing":"0001472343-16-000197","document":"wf-form4_147466266692520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403893/000147234316000197/wf-form4_147466266692520.xml","form_type":"4"}},{"id":4596068,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2016-09-23T16:31:19.000Z","date":"2016-09-21","kind":"purchase","acquired":true,"shares":25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person purchased 25 Series A Preferred Shares and five-year warrants to purchase 35,714 Common Shares at a purchase price of $1,000 per share pursuant to a private offering of the Company for a total of $25,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock and the lock up agreement dated September 21, 2016, reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the \"Series A Preferred Shares\")  automatically converts, upon receipt by the Company of shareholder approval, into shares of the Company's common stock, par value $0.001 (the \"Common Shares\") at a conversion price of $0.70 per share. The Series A Preferred Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock and the lock up agreement dated September 21, 2016, reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the \"Series A Preferred Shares\")  automatically converts, upon receipt by the Company of shareholder approval, into shares of the Company's common stock, par value $0.001 (the \"Common Shares\") at a conversion price of $0.70 per share. The Series A Preferred Shares have no expiration date."}],"balance_after":25,"derivative":{"exercise_price":0.7,"underlying":"Common stock, par value $0.001 per share","underlying_shares":35714},"source":{"system":"sec-edgar","filing":"0001472343-16-000197","document":"wf-form4_147466266692520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403893/000147234316000197/wf-form4_147466266692520.xml","form_type":"4"}}]}